Personalized Antibodies For Gastroesophageal Adenocarcinoma (Pangea): Primary Efficacy Analysis Of The Phase Ii Platform Trial (Nct02213289)

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 10|浏览107
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要